Wright Medical Group N.V. (NASDAQ: WMGI) was one of the biggest movers in the recent trading session. So what do we make of this stock that is clearly one of the hottest on the market now? The WMGI stock is trading at $30.14 from a close of $30.40 on 01/15/20. The day’s price range saw the stock hit a low of $30.06, while the highest price level was $30.40 during the intraday trading.
Is the WMGI stock going to continue the plunge or will it steady in coming sessions to climb above its 5-day high price of $30.49. Wright Medical Group N.V. (NASDAQ: WMGI) has a 52-week price range of between $19.04 and $32.86. Notably, the reduced performance in the current session comes on the back of condensed market activity for the stock, as its daily trading volume to 4396923, compared to its 3-months daily average volume of 5.33 million. In comparison, the average volume for the last 50 days stands at 5,910,424.
What about the stock’s price forecasts? WMGI had 12 analysts who offered their 12-month price predictions for the Wright Medical Group N.V. shares. The group has given the stock a consensus price target of $30.55, with the lowest forecast being put at $29.00. The highest estimate by the 12 analysts is $31.00. The median price target estimate of $30.75 for the stock represents a 1.98% jump in value from the previous price of $30.14. Looking at the 52-week price ranges, the stock’s current price level is 58.30% from its 52-week high price and -8.28% down from its 52-week low in the same period.
Wright Medical Group N.V. shares have plunged -0.86% over the past week, but its 1-month performance is in the green at 1.21%. Its performance in the current quarter is up 48.29%, while that figure shoots to 13.61% over the past half-year period. Further, we see that the stock’s 12-month charts show that it has gained by 5.61%, with the year-to-date prices down by -1.12%.
The company has a market cap of 3.81 billion and a return on assets (ROA) of -4.90%. In gauging how profitable company analysts and investors look at the respective company’s ROA, with returns above 5% generally regarded as good. Also important is the company’s return on equity (ROE), with WMGI’s at -14.60% indicating that the management is able to generate impressive income with whatever equity at their disposal. If you put your money on this stock, then a forecast ROI is at -0.40%.
But what do Wall Street analysts tracking this stock recommend, given that it has 126.57 million shares outstanding? 12 analysts polled have a consensus recommendation rating of 3.38, indicating that WMGI is a Hold stock at the moment. This mean rating was at 3.54 a month ago. Jefferies called it a Hold stock on December 24, 2019, while SVB Leerink rated it a Mkt Perform in its note released on November 18, 2019. Of the 12 analysts, 0 analysts rate the WMGI stock as Overweight, while 10 of them rated it as a Hold. 2 analysts rate Wright Medical Group N.V. as a Buy, while 0 suggested its Underweight. Only 0 analyst advised investors to sell.
Let’s glean at the company’s earnings forecasts for the current quarter and annual growth estimate for the next 5-year period. The analyst forecasts for this stock’s earnings per share (EPS) for the current quarter (Dec 2019) ranged from a low of $0.14 per share to $0.19 per share. The average estimate by the 11 analysts for the WMGI shares was $0.17 a share, while the company’s last-quarter results returned an EPS of $0.05. Looking at the current EPS trends, seven days ago, WMGI had its Dec 2019 estimates at $0.17 per share while the stock’s EPS was forecasted at the $0.17, a month ago. However, the company’s EPS growth for this quarter stands at 54.50%, while that growth rate for the next fiscal quarter is forecasted at 60.00%.
Let’s briefly check out revenue growth estimates for the company, which is put at 8.80% in the current quarter. However, the next quarter should see net revenue growth of over 9.30%, with analysts forecasting the company’s 12-month growth estimates at 9.70%. 12 analysts have forecast that Wright Medical Group N.V. will see its revenue growth net between $257.2 million and $261.6 million for the current quarter. The next quarter should see revenue returns of between $240.8 million and $250.26 million.The average revenue for the quarter is expected at $259.14 million, while for the next quarter, it jumps to $247.19 million. Sales growth for the year are estimated at 9.70%.